It is well established that pathologic tau is strongly correlated with neurodegeneration in AD patients, indicating that pathologic tau contributes to neuronal loss and brain atrophy (La Joie et al., 2020; Xia et al., 2017). Here, MAPT is linked to Brain atrophy.